Clinical Trial Update: Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on a Phase 2/Phase 3 study evaluating intra-detrusor injections of botulinum toxin A (Botox) at the time of HoLEP to treat men with overac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Northwestern University | Conditions: Urinary Incontinence, Overactive Bladder Syndrome | Phase 2, Phase 3 | Status: RECRUITING